Hims & Hers Health (HIMS) Non-Current Deferred Tax Liability (2025 - 2026)

Hims & Hers Health (HIMS) reported Non-Current Deferred Tax Liability of $23.5 million for Q1 2026, down 18.52% sequentially from $28.9 million in Q4 2025.

Hims & Hers Health (HIMS) Non-Current Deferred Tax Liability (2025 - 2026) Analysis & Trends

Hims & Hers Health (HIMS) has 2 years of Non-Current Deferred Tax Liability data on file, last reported at $23.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Deferred Tax Liability changed N/A year-over-year to $23.5 million; the trailing twelve-month figure through Mar 2026 stood at $23.5 million (changed N/A YoY), and the FY2025 full-year result was $28.9 million, changed N/A from the prior year.
  • Non-Current Deferred Tax Liability retreated to $23.5 million in Q1 2026, from $28.9 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $31.2 million in Q3 2025 to a low of $23.5 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 88.07 Bn 86.20 Bn -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn
10 Hims & Hers Health 6.44 Bn 5.69 Bn 396.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 23.51 Mn
Mar 31, 2026 23.51 Mn
Dec 31, 2025 28.86 Mn
Dec 31, 2025 28.86 Mn
Sep 30, 2025 31.21 Mn
Sep 30, 2025 31.21 Mn